Elastomeric Infusion Pumps Market Regional Analysis:
North American Market Insights
North America region is set to dominate around 40.8% market share by 2035. As reported by Centers for Disease Control and Prevention (CDC), America’s chronic diseases account for USD 4.1 Trillion in healthcare spending annually. Nearly six in every ten Americans (6 out of every 10 people) have at least one of the chronic diseases listed in the CDC’s list of chronic diseases.
Heart disease, stroke, colorectal cancer, and diabetes are among the most common chronic diseases in the United States. These chronic diseases are the leading cause of death and disability, and they are also the leading cause of healthcare spending through the use of basic healthcare tools, such as elastomer infusion pumps, across North America.
The US has a well-developed healthcare system, with a large number of specialized care facilities, which puts elastomeric pumps in high demand for pain management and chemotherapy, as well as other applications.
The increasing geriatric population, which is more susceptible to chronic diseases and other related disorders, is increasing the need for hospitalization and intravenous medication for home care, which is also expected to drive elastomeric infusion pumps market growth in Canada. For example, in Canada, a large proportion of the population is between 15 and 64 years old according to statistics published by the United Nations Population Fund for 2022 which represents 65 % of the total population.
European Market Insights
By 2035, European region is estimated to account for significant elastomeric infusion pumps market share. Like other regions in the world, Europe has a high burden of chronic diseases such as cancer, diabetes, and cardiovascular diseases. For example, noncommunicable diseases (NCDs) such as cardiovascular disease (CVD), diabetes (CVD), chronic respiratory disease (CRD), mental disorders (MDS), neurological disorders (NMD), and cancer (CJD) represent 80% of disease burden in the EU countries and account for the majority of preventable early deaths. The human and economic costs of NCDs are considerable and are expected to increase as the EU population ages.
The increasing adoption of home healthcare solutions and the demand for patient-centric medical equipment, as well as an increase in healthcare services such as ambulatory surgery and postoperative care in the United Kingdom, are contributing to this growth.
The adoption of elastomer infusion pumps across the continent has been reinforced by a Germany focus on healthcare effectiveness, patients' safety, and sustainable health care practices which have marked them as a significant elastomeric infusion pumps market for these indispensable tools.
The strong presence of the main players, availability of advanced healthcare infrastructure, and technical innovation which has an impact on market development in France.
